Work

Abstract 514: Potentiation ofPARP inhibitor activity in BRCA -wildtype breast cancer cell lines by 2-hydroxyflavanone.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-514

Authors: Harshit Khosla, Sharda P. Singh, Chhanda Bose, Sharad S. Singhal, Sanjay Awasthi

Institutions: The University of Texas Health Science Center at Houston, Texas Tech University, Texas Tech University Health Sciences Center, City Of Hope National Medical Center, City of Hope, Beckman Research Institute

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148840016

Cites:

Cited by:

Related to: